{"nct_id":"NCT04181788","title":"Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-06","start_date":"2020-03-18","start_date_type":"ACTUAL","primary_completion_date":"2022-03-03","primary_completion_date_type":"ACTUAL","completion_date":"2026-06-09","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["PFE"]}